FOLFIRI + targeted therapy vs FOLFIRI
Tumour response · people with metastatic CRC
FOLFIRI + targeted therapy probably leads to higher overall tumour response compared with FOLFIRI (moderate certainty).
1 finding from 1 review
- Second‐line systemic therapy for metastatic colorectal cancer 2017 · Cochrane Headline outcomes onlyRR 2.07 [1.31, 3.28]6 studies · 3192 participantsModerate